- Home
- MTSI vs DGX Comparison
MTSI vs DGX Comparison
Compare MTSI & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | DGX |
|---|---|---|
| Founded | 1950 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0B | 23.2B |
| IPO Year | 2011 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MTSI | DGX |
|---|---|---|
| Price | $312.14 | $236.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $257.60 | $214.38 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | 2.52 | ★ 5.08 |
| Revenue | $967,258,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $23.55 | $7.53 |
| Revenue Next Year | $17.74 | $3.77 |
| P/E Ratio | $122.73 | ★ $46.81 |
| Revenue Growth | ★ 32.58 | 11.78 |
| 52 Week Low | $118.28 | $171.18 |
| 52 Week High | $418.90 | $240.13 |
Technical Indicators
Market Signals| Indicator | MTSI | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 68.04 |
| Support Level | $257.93 | $191.82 |
| Resistance Level | $407.28 | $240.13 |
| Average True Range (ATR) | 17.38 | 4.61 |
| MACD | 8.83 | -0.27 |
| Stochastic Oscillator | 90.63 | 72.87 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.